Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections.
Pession
A
A
Department of Pediatrics, University of Bologna, Ospedale Sant'Orsola, Bologna, Italy. pession@med.unibo.it
Castellini
C
C
Prete
A
A
Locatelli
F
F
Urbini
B
B
Paolucci
G
G
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002648:Child; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000008:administration & dosage*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D010960:Plasminogen Activators / Q000008:administration & dosage*; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000209:etiology; D012231:Rhizobium / Q000302:isolation & purification*; D016879:Salvage Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator